Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
135 hedge funds and large institutions have $578M invested in Surmodics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 56 reducing their positions, and 20 closing their positions.
1.03% more ownership
Funds ownership: 90.17% → 91.2% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less capital invested
Capital invested by funds: $607M → $578M (-$28.9M)
9% less funds holding
Funds holding: 148 → 135 (-13)
27% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 56
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
82% less call options, than puts
Call options by funds: $45K | Put options by funds: $249K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.71M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$5.63M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$5.32M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.05M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.77M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.7M |
| 3 |
Renaissance Technologies
New York
|
-$1.49M |
| 4 |
Goldman Sachs
New York
|
-$1.48M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.46M |
SRDX Hedge Fund Activity: Q1 2022 in Review
135 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2022, worth a combined $578M — down 4.8% from $607M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of SRDX and 8 opened new positions — a net loss of 12 holders — while 56 trimmed existing stakes and 41 added.
The largest buyer was Millennium Management, adding an estimated $5.71M. The largest seller was Geode Capital Management, cutting an estimated $2.77M.
- 135 institutional investors held Surmodics (SRDX) as of Q1 2022, down from 148 in Q4 2021.
- Funds reported $578M of Surmodics stock for Q1 2022, down 4.8% quarter-over-quarter.
- 8 funds opened new Surmodics positions in Q1 2022 and 20 closed out, a net change of -12 holders.
- The largest Surmodics buyer in Q1 2022 was Millennium Management, an estimated $5.71M added.
- The largest Surmodics seller in Q1 2022 was Geode Capital Management, an estimated $2.77M sold.
Based on aggregated 13F filings for Q1 2022.